Stacey M C, Mata S D
Department of Surgery, University of Western Australia, Fremantle Hospital, PO Box 480, Fremantle, Australia.
Cardiovasc Surg. 2000 Aug;8(5):381-5. doi: 10.1016/s0967-2109(00)00028-4.
Plasminogen activators may potentially influence the wound healing processes of cell migration, matrix degradation and cellular adhesion in venous ulcers by their regulation of protease activity. The aim of this study was to assess the levels of plasminogen activators in venous ulcers and to gain preliminary data from healing wounds. The concentrations of u-PA, t-PA, PAI-1 and PAI-2 antigen as well as functional u-PA were assessed in tissue homogenates from 20 chronic venous ulcers, six actively healing venous ulcers and five traumatic wounds. The concentrations of functional u-PA, u-PA antigen and PAI-1 were significantly greater and PAI-2 was significantly lower in the edge and base of chronic venous ulcers compared to adjacent intact skin (P<0.01). Healing wounds had significantly higher functional u-PA at the ulcer edge and higher u-PA antigen concentration in intact skin (P<0.05). PAI-2 levels were significantly higher in the ulcer edge and base in the healing wounds than in chronic venous ulcers (P<0.05). These findings suggest that regulation of protease activity by u-PA and PAI-2 may play a role in the impaired healing of chronic venous ulcers.
纤溶酶原激活剂可能通过调节蛋白酶活性,潜在地影响静脉溃疡中细胞迁移、基质降解和细胞黏附等伤口愈合过程。本研究旨在评估静脉溃疡中纤溶酶原激活剂的水平,并从愈合伤口获取初步数据。在来自20例慢性静脉溃疡、6例正在积极愈合的静脉溃疡和5例创伤伤口的组织匀浆中,评估了尿激酶型纤溶酶原激活剂(u-PA)、组织型纤溶酶原激活剂(t-PA)、纤溶酶原激活剂抑制物-1(PAI-1)和纤溶酶原激活剂抑制物-2(PAI-2)抗原的浓度以及功能性u-PA。与相邻的完整皮肤相比,慢性静脉溃疡边缘和底部的功能性u-PA、u-PA抗原和PAI-1浓度显著更高,而PAI-2显著更低(P<0.01)。愈合伤口在溃疡边缘的功能性u-PA显著更高,在完整皮肤中的u-PA抗原浓度更高(P<0.05)。愈合伤口溃疡边缘和底部的PAI-2水平显著高于慢性静脉溃疡(P<0.05)。这些发现表明,u-PA和PAI-2对蛋白酶活性的调节可能在慢性静脉溃疡愈合受损中起作用。